Project description DEENESFRITPL Finding a solution for AMR Antimicrobial resistance (AMR) is a major global threat to human and animal health. Medicines that were once effective treatments for disease are becoming less so, leading to a reduced ability to successfully treat infections. The EU-funded ABOLED project is investigating the commercial viability of an alternative approach to this problem. AMR is responsible for an estimated 33 000 deaths per year in the EU. It is also estimated that AMR costs the EU EUR 1.5 billion per year in healthcare costs and productivity losses. Only 25 % of countries have implemented a national policy to tackle AMR. Less than 40 % of countries have put in place infection prevention and control programmes for AMR. Show the project objective Hide the project objective Objective Multidrug resistance of pathogenic bacteria has become a serious threat to public health. The need to develop novel technologies to combat the evolution of bacterial drug resistance is clearly a matter of public concern and urgency. The consequences of AMR include (i) reducing our ability to treat common infectious, resulting in prolonged illness and a greater risk of complications; (ii) patients remaining infectious for longer due to ineffective treatments, making them more likely to pass infections on to others; (iii) compromising advances in modern medicine (such as organ transplantation or chemotherapy) due to risk of infection; and (iv) increasing economic burden on health care systems, families, and societies. This project aims to assess the commercial viability of an alternative approach to this problem. Fields of science medical and health scienceshealth sciencespublic healthnatural sciencesbiological sciencesmicrobiologybacteriologymedical and health sciencesclinical medicinetransplantationmedical and health sciencesbasic medicinepharmacology and pharmacydrug resistancemultidrug resistance Programme(s) H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme Topic(s) ERC-2019-POC - ERC Proof of Concept Grant Call for proposal ERC-2019-PoC See other projects for this call Funding Scheme ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot Host institution THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS Net EU contribution € 150 000,00 Address NORTH STREET 66 COLLEGE GATE KY16 9AJ St Andrews United Kingdom See on map Region Scotland Eastern Scotland Clackmannanshire and Fife Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost No data Beneficiaries (1) Sort alphabetically Sort by Net EU contribution Expand all Collapse all THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS United Kingdom Net EU contribution € 150 000,00 Address NORTH STREET 66 COLLEGE GATE KY16 9AJ St Andrews See on map Region Scotland Eastern Scotland Clackmannanshire and Fife Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost No data
